UK’s NICE Backs BMS's Opdivo In Lung Cancer, But Only Via CDF With Price Cut

 
• By Sten Stovall
  
xray
NICE Backs Opdivo For Lung Cancer After BMS Agrees CDF Deal • Source: Shutterstock

More from Market Access

More from Pink Sheet